SWK HOLDINGS CORPORATION (OTCMKTS:SWKH) Files An 8-K Other Events
Item 8.01. Other Events.
Parnell, Inc.
On November 22, 2016, SWK Funding LLC (SWK Funding), a
wholly-owned subsidiary of SWK Holdings Corporation (the
Company), entered into a Credit Agreement to which the lenders
party thereto provided to Parnell, Inc., a leading global
veterinary pharmaceutical business incorporated under the laws of
the state of Delaware (Borrower), a term loan in the principal
amount of $20,000,000 (the Loan).SWK Funding provided $13,500,000
and other non-SWK affiliated lenders provided the remaining
$6,500,000 of the Loan.SWK Funding serves as the Agent, Sole Lead
Arranger and Sole Bookrunner under the Credit Agreement.
The loan was fully funded at closing and has a 48-month term,
being interest-only for the first 24 months with interest payable
quarterly in arrears. The Loan matures on November 22, 2020.
to the terms of the Credit Agreement, the Borrower granted the
lenders a first priority security interest in substantially all
of the Borrowers assets. The Credit Agreement contains certain
affirmative and negative covenants. The Borrowers U.S., U.K.,
Australian and New Zealand affiliates have guaranteed the
Borrowers obligations under the Credit Agreement.
Entry Into Additional Term Sheets
Separate from the Parnell transaction above, the Company has
executed three term sheets under which, if consummated, the
Company would deploy up to $33.7 million over the next
approximately 90 days. There is no guarantee that SWK will close
such transactions as they remain subject, in each case, to
completion of due diligence and legal documentation. SWK does not
plan to provide any further updates with respect to these
potential transactions until each one is closed. SWK does not
anticipate providing forward-looking comments on signed terms
sheets going forward.
Safe Harbor Statement
This Current Report on Form 8-K contains forward-looking
statements within the meaning of the Private Securities
Litigation Reform Act of 1995. Statements including words such as
believes, expects, anticipates, intends, estimates, plan, will,
would, may, look forward, intend, guidance, future or similar
expressions are forward-looking statements. Because these
statements reflect the Companys current views, expectations and
beliefs concerning future events, these forward-looking
statements involve risks and uncertainties. Investors should note
that many factors, as more fully described under the caption Risk
Factors in the Companys Form 10-K, Form 10-Q and Form 8-K filings
with the Securities and Exchange Commission and as otherwise
enumerated herein or therein, could affect the Companys future
financial results and could cause actual results to differ
materially from those expressed in such forward-looking
statements. The forward-looking statements in this Current Report
are qualified by these risk factors. These are factors that,
individually or in the aggregate, could cause the Companys actual
results to differ materially from expected and historical
results. You should not place undue reliance on any
forward-looking statements, which speak only as of the date they
are made. We assume no obligation to publicly update any
forward-looking statements, whether as a result of new
information, future developments or otherwise.
About SWK HOLDINGS CORPORATION (OTCMKTS:SWKH)
SWK Holdings Corporation is a healthcare capital provider. The Company offers financing solutions to a range of life science companies, institutions and inventors. The Company’s focus is on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. The Company, through its subsidiary SWK Advisors LLC, provides non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. It focuses to fund transactions through its own working capital, as well as by building its asset management business by raising additional third party capital to be invested alongside its capital. The Company evaluates and invests in a range of healthcare related companies and products. SWK HOLDINGS CORPORATION (OTCMKTS:SWKH) Recent Trading Information
SWK HOLDINGS CORPORATION (OTCMKTS:SWKH) closed its last trading session up +0.40 at 9.85 with 1,117 shares trading hands.